South Korea's post-procedure skincare market is gaining traction as medical tourism hits a record high, with 74% of foreign patients seeking aesthetic treatments in 2025. This trend signals growing demand for high-performance recovery cosmetics, particularly those containing PDRN, creating new sourcing opportunities for overseas buyers in the medical aesthetics supply chain.
Market signal
According to the Ministry of Health and Welfare, the number of foreign patients visiting South Korea reached 2,011,822 in 2025, surpassing pre-COVID levels and marking a 71% increase year-on-year. The top nationalities were China, Japan, and Taiwan, with aesthetic medical procedures—including dermatology and plastic surgery—accounting for 74% of all treatments.
This influx is fueling demand for post-procedure cosmetics focused on skin barrier recovery, soothing, and elasticity. The market is increasingly centered on PDRN (polydeoxyribonucleotide), a DNA-derived ingredient from fish reproductive cells known for skin regeneration and anti-inflammatory benefits.
Key players and product expansion
Pharmaceutical companies are leading the charge. Pharmaresearch, with its Rejuran cosmetic line, reported a 51% year-on-year increase in Q1 cosmetic sales, driven by functional product demand. Its proprietary 'DOT c-PDRN' ingredient is used in products like the Rejuran Synergy Booster, designed for post-procedure recovery. The company is expanding globally through Amazon, Sephora, and recently entered Olive Young's new U.S. store.
Dongkuk Pharmaceutical's 'Centellian24' brand leverages TECA (Centella Asiatica extract) for post-laser soothing and barrier strengthening. It recently launched 'Madeca PDRN Glass' with 10,000ppm PDRN for hydration and calming. APR, through its MediCube brand, has expanded its PDRN line to include ampoules, collagen masks, and tone-up sunscreens, with cumulative sales exceeding 50 million units, driven by U.S. and Japanese markets.
Sourcing context
Skin1004 entered the market with 'Madagascar Centella PDRN 1.5 Cream', featuring 99% purity Biome PDRN combined with 8GF and zinc hyaluronic acid, targeting sensitive skin recovery after laser procedures. The ingredient is produced via sustainable fermentation, appealing to eco-conscious buyers.
Olive Young, South Korea's largest multi-brand beauty retailer, has responded by renovating its Apgujeong Rodeo store into a 'Global Medical Tourism Specialty Store', offering post-procedure skincare, beauty devices, and inner beauty products. It also launched an 'Advanced Derma' category in March, featuring domestic derma brands in high-traffic stores like Myeongdong and Seongsu. Foreigners now account for 90% of functional cosmetics sales growth in Olive Young's offline stores from 2023 to 2025.
What buyers should watch
Overseas distributors and clinic buyers should monitor the PDRN trend as a key growth segment in K-beauty. The ingredient's proven efficacy in post-procedure recovery aligns with rising global demand for medical aesthetics. Sourcing from established Korean pharmaceutical companies or emerging indie brands like Skin1004 offers opportunities, but buyers should verify ingredient purity and regulatory compliance for their target markets.
Source: Read the original report | Published: June 15, 2026